Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting learning session on understanding the best treatment approaches of ALK positive lung cancer.
In this webinar, a panel discussion would take place involving Dr. Todd Bauer as the primary speaker and Dr. Ullas Batra as a moderator who will share the important facts associated with treatment approaches for management of ALK positive lung cancer.
Dr. Todd Bauer has explained all details associated with the incidence, progression and treatment of ALK positive lung cancer. Further, a discussion on all possible treatment approaches and their pros, cons are discussed.
ALK-positive lung cancer represents about 4% of lung cancer which generally appears in adenocarcinoma non-small cell lung cancer. Patients with ALK-positive are mostly younger than the average lung cancer patient and also do not have a smoking history compared to other lung cancers.
Therefore, you are going to have an overall knowledge regarding management of ALK positive lung cancer. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
2.
These Athletes Weren't Doping. Their Genes Made It Look Like They Did.
3.
Understudied mental health challenges among caregivers of cancer patients: A call for targeted support
4.
Women are more susceptible to the stress caused by inflation.
5.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
1.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
2.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
3.
The Mystery of Carotid Body Tumors: The Facts You Need to Know
4.
Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology
5.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
5.
Understanding the causes of anemia in adults beyond nutritional deficiencies
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation